Physician profile
Jordan Luke Sikes
NPI 1104155191
$14,794.85
in general payments reported to CMS, 2019-2025
25 companies · $1,301 in 2025
The $1,301 reported for 2025 was more than what 75% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $874 · 2020: $954 · 2021: $3,425 · 2022: $1,685 · 2023: $4,300 · 2024: $2,257 · 2025: $1,301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,613 · Travel and Lodging: $1,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,612.74 |
| Travel and Lodging | $1,244.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $11,481.84 | 2019-2025 | Ortholoc 2 Lapifuse, Viaflow, Augment Injectable |
| Smith+Nephew, INC. | $1,369.10 | 2019-2025 | Grafix Pl, Collagenase Santyl, Stravix Pl |
| Horizon Therapeutics Plc | $443.56 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $361.70 | 2023 | |
| Paratek Pharmaceuticals, INC. | $224.76 | 2021-2024 | Nuzyra |
| Integra Lifesciences Corporation | $154.16 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $116.43 | 2019-2025 | Novachor |
| Treace Medical Concepts, INC. | $109.28 | 2022-2025 | |
| Kerecis Limited | $99.60 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Averitas Pharma INC. | $61.69 | 2023-2025 | Qutenza |
| Orpyx Medical Technologies US INC. | $53.38 | 2023 | Orpyx Si |
| Osiris Therapeutics INC. | $43.84 | 2019 | |
| Misonix INC | $43.37 | 2020 | |
| Wardlow Enterprises | $32.27 | 2023 | |
| Kci USA, INC. | $24.80 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $22.01 | 2024 | Irrisept |
| Orthofix Medical, INC. | $21.43 | 2025 | Accelstim |
| Solventum Corporation | $20.05 | 2025 | Activ.A.C. |
| Grt US Holding, INC. | $19.14 | 2022 | |
| Rsw Medical Company, INC. | $17.99 | 2019 | |
| Conetic Solutions, INC. | $16.42 | 2022 | |
| Nevro Corp. | $16.38 | 2022 | |
| Lifenet Health | $16.07 | 2024 | Theragenesis Wound Matrix |
| Zimmer Biomet Holdings, INC. | $13.62 | 2022 | |
| Merck Sharp & Dohme LLC | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Sikes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.